IL6 and obesity due to melanocortin 4 receptor deficiency: Paradoxically, work from our laboratory and others have highlighted that complete ablation of IL-6 in mice can lead to deleterious metabolic consequences such as glucose intolerance, obesity and more importantly increased liver steatosis and damage [9–11].